4771 - 4780 of 8666 Results
Title
Year
-
OPENTitle: Phenotypic characterization of recessive gene knockout rat models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 70Issue #:Start Page: 190End Page: 203Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1016/j.nbd.2014.06.009Best OA location URL: https://doi.org/10.1016/j.nbd.2014.06.009Citation Count: 219
-
OPENTitle: A proteogenomic view of Parkinson’s disease causality and heterogeneityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00461-9Best OA location URL: https://www.nature.com/articles/s41531-023-00461-9.pdfCitation Count: 36
-
OPENTitle: Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 5Issue #: 11Start Page: 917End Page: 923Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(06)70579-8Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3636768Citation Count: 88
-
RESTRICTEDTitle: Real-World Experience With VMAT2 InhibitorsJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 42Issue #: 2Start Page: 37End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000326Citation Count: 45
-
RESTRICTEDTitle: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience DataJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 2Start Page: e28End Page: e29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088Citation Count: 0
-
OPENTitle: The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBAJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1216End Page: 1228Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28472Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28472Citation Count: 62
-
OPENTitle: Precision medicine for Parkinson’s disease: The subtyping challengeJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1064057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1064057/pdfCitation Count: 8
-
OPENTitle: Data Sharing Goals for Nonprofit Funders of Clinical TrialsJournal Name: Journal of Participatory MedicinePublisher: JMIR Publications Inc.Vol: 13Issue #: 1Start Page: e23011End Page: e23011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/23011Best OA location URL: https://jopm.jmir.org/2021/1/e23011/PDFCitation Count: 4
-
OPENTitle: Paraquat Neurotoxicity is Distinct from that of MPTP and RotenoneJournal Name: Toxicological SciencesPublisher: Oxford University Press (OUP)Vol: 88Issue #: 1Start Page: 193End Page: 201Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/toxsci/kfi304Best OA location URL: https://academic.oup.com/toxsci/article-pdf/88/1/193/4676394/kfi304.pdfCitation Count: 264
-
OPENTitle: Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s diseaseJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 3Issue #: 6Start Page: 100661End Page: 100661Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100661Best OA location URL: https://doi.org/10.1016/j.xcrm.2022.100661Citation Count: 124